HOME >> BIOLOGY >> NEWS
Tweaking the treatment for restless legs

"The best drugs for restless leg syndrome sometimes can only work for a time. Then they boomerang."

Last Super Bowl, a TV commercial lauded the power of Requip (ropinirole), the first drug approved to treat restless leg syndrome, a condition whose signature feature is creepy-crawly leg sensations that interfere with sleep and rest in nearly 1 of every 10 adults.

But if taken too long, the drug can actually backfire, causing symptoms to worsen, say doctors who specialize in treating the condition. They say that treatment that rotates through different types of medications may be needed for many patients.

"Its impossible to tell the whole story in a TV spot just a few seconds long," said Irene Richard, M.D, a movement disorder neurologist at the University of Rochester Medical Center. "When patients come in asking about the treatment, doctors need to know that this is usually not a simple, single-pill solution, despite what theyve seen on TV."

In an article published in the December issue of the Journal of General Internal Medicine, Richard and fellow neurologist Roger Kurlan, M.D., warn primary care physicians that they cannot expect long-term success by simply prescribing ropinirole or a similar medication in its class, which works by activating dopamine receptors in the brain. Instead, the team experts at treating movement disorders like Parkinsons disease, Tourettes syndrome and restless leg syndrome recommends that physicians may need to rotate some patients through these drugs along with different types of medications.

"The truth is, some of the most common, most effective drugs, including ropinirole and pramipexole, which was recently approved to treat restless leg syndrome, may only work effectively for each person for a limited time," Kurlan said. "After that, this class of drugs albeit the most-popular, effective, and the only one approved by the Food and Drug Administration for restless leg syndrome has a regre
'"/>

Contact: Becky Jones
rebecca_jones@urmc.rochester.edu
585-275-8490
University of Rochester Medical Center
20-Dec-2006


Page: 1 2 3

Related biology news :

1. Tweaking Taxol points way to a greener, more productive future
2. New system of wastewater treatment could reduce the size of treatment plants by half
3. UCF research links proteins, stem cells and potential Alzheimers treatment
4. Geisinger scientist seeks cure for Lou Gehrigs disease, creating device to find treatment
5. System to analyze beating heart stem cells could lead to heart attack treatments
6. Gene expression pattern could lead to improved treatment of pediatric septic shock
7. Molecular detectors may refine cancer treatment
8. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
9. A new method of adult stem cell growth efficacious in treatment of disorders of the cornea
10. Scientists take next step in understanding potential target for ovarian cancer treatment
11. New treatment model for HIV

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Tweaking the treatment for restless legs

(Date:5/17/2013)... finds human-caused climate change may have little impact ... host of recent studies that predict their widespread ... findings, which appear in the journal Global ... of a creature thought to be doomed: ... animals, especially forest lizards, will be hard hit ...
(Date:5/16/2013)... MD FASEB MARC (Maximizing Access to Research ... for The Society for Developmental Biology (SDB) 72nd ... 2013. These awards are meant to promote the ... groups into the mainstream of the basic science ... scientists at the SDB 2013 Annual Meeting. , ...
(Date:5/16/2013)... lining the body,s blood vessels, is extremely resilient. ... this super-tenuous structure routinely withstands blood flow, hydrostatic ... unique and highly dynamic barrier that maintains the ... circulatory system. , It,s also extremely adaptable. In ... to enable immune cells to reach various ...
Breaking Biology News(10 mins):Climate change may have little impact on tropical lizards 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4
(Date:5/17/2013)... Dr. Sparano is Professor of Medicine and ... Albert Einstein College of Medicine and Associate Chairman of ... He is also Associate Director for Clinical Research ... Breast Cancer Working Group, a multidisciplinary group of physicians ... also serves as Vice Chair of the National Cancer ...
(Date:5/17/2013)... available in German . ... the naked eye, you can see which branch a bird ... of branches through the telephoto lens for high-magnification images requires ... are looking to study proteins, the active biomolecules of cells. ... for Molecular Systems Biology, and her colleagues have now come ...
(Date:5/17/2013)... USA (PRWEB) May 17, 2013 •    First ... Globes Certified for sustainability ,     New facility will ... , Syngenta unveiled its new ... at the company’s RTP Innovation Center. The first of ... researchers to simulate any agricultural climate and precisely measure ...
(Date:5/17/2013)... , May 17, 2013  Yongye International, Inc. ... a leading developer, manufacturer, and distributor of crop nutrient ... , today announced that, on May 16, 2013, ... of directors (the "Board of Directors") was provided a ... Hong Kong ) Limited ("Abax") to Full ...
Breaking Biology Technology:Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4
Cached News: